Logo image of TNMG

TNL MEDIAGENE (TNMG) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:TNMG - KYG8924F1054 - Common Stock

2.6 USD
+2.46 (+1757.14%)
Last: 12/23/2025, 2:47:35 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to TNMG. TNMG was compared to 94 industry peers in the Media industry. TNMG may be in some trouble as it scores bad on both profitability and health. TNMG is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

TNMG had negative earnings in the past year.
TNMG had a negative operating cash flow in the past year.
In multiple years TNMG reported negative net income over the last 5 years.
In the past 5 years TNMG always reported negative operating cash flow.
TNMG Yearly Net Income VS EBIT VS OCF VS FCFTNMG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 -20M -40M -60M -80M

1.2 Ratios

Looking at the Return On Assets, with a value of -91.43%, TNMG is doing worse than 85.11% of the companies in the same industry.
With a Return On Equity value of -233.38%, TNMG is not doing good in the industry: 79.79% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -91.43%
ROE -233.38%
ROIC N/A
ROA(3y)-28.56%
ROA(5y)N/A
ROE(3y)-75.91%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
TNMG Yearly ROA, ROE, ROICTNMG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 -50 -100 -150 -200

1.3 Margins

TNMG has a Gross Margin of 36.58%. This is comparable to the rest of the industry: TNMG outperforms 46.81% of its industry peers.
The Profit Margin and Operating Margin are not available for TNMG so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 36.58%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
TNMG Yearly Profit, Operating, Gross MarginsTNMG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 -50 -100 -150

More info and screens

1

2. Health

2.1 Basic Checks

TNMG does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, TNMG has about the same amount of shares outstanding.
Compared to 1 year ago, TNMG has a worse debt to assets ratio.
TNMG Yearly Shares OutstandingTNMG Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 5M 10M 15M 20M
TNMG Yearly Total Debt VS Total AssetsTNMG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

TNMG has a Debt/Equity ratio of 0.16. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.16, TNMG is in the better half of the industry, outperforming 70.21% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC5.53%
TNMG Yearly LT Debt VS Equity VS FCFTNMG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

TNMG has a Current Ratio of 0.54. This is a bad value and indicates that TNMG is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of TNMG (0.54) is worse than 82.98% of its industry peers.
A Quick Ratio of 0.53 indicates that TNMG may have some problems paying its short term obligations.
TNMG has a Quick ratio of 0.53. This is amonst the worse of the industry: TNMG underperforms 82.98% of its industry peers.
Industry RankSector Rank
Current Ratio 0.54
Quick Ratio 0.53
TNMG Yearly Current Assets VS Current LiabilitesTNMG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 10M 20M 30M

More info and screens

4

3. Growth

3.1 Past

The earnings per share for TNMG have decreased strongly by -10553.80% in the last year.
The Revenue has grown by 35.31% in the past year. This is a very strong growth!
EPS 1Y (TTM)-10553.8%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%27.17%
Revenue 1Y (TTM)35.31%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%5.72%

3.2 Future

The Earnings Per Share is expected to grow by 41.42% on average over the next years. This is a very strong growth
TNMG is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 24.40% yearly.
EPS Next Y92.72%
EPS Next 2Y41.42%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year22.35%
Revenue Next 2Y24.4%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

TNMG Yearly Revenue VS EstimatesTNMG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 20M 40M 60M
TNMG Yearly EPS VS EstimatesTNMG Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 -0.05 -0.1 -0.15 -0.2 -0.25

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for TNMG. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TNMG Price Earnings VS Forward Price EarningsTNMG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
TNMG Per share dataTNMG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 -2 -3

4.3 Compensation for Growth

TNMG's earnings are expected to grow with 41.42% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.42%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

TNMG does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

TNL MEDIAGENE

NASDAQ:TNMG (12/23/2025, 2:47:35 PM)

2.6

+2.46 (+1757.14%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.13%
Inst Owner ChangeN/A
Ins Owners20.51%
Ins Owner ChangeN/A
Market Cap107.41M
Revenue(TTM)48.49M
Net Income(TTM)-84.95M
Analysts82.86
Price Target3.57 (37.31%)
Short Float %4.01%
Short Ratio0.1
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-92.31%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.65%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.21
P/FCF N/A
P/OCF N/A
P/B 2.95
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-3.51
EYN/A
EPS(NY)0
Fwd EYN/A
FCF(TTM)-0.47
FCFYN/A
OCF(TTM)-0.27
OCFYN/A
SpS1.17
BVpS0.88
TBVpS-0.69
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -91.43%
ROE -233.38%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 36.58%
FCFM N/A
ROA(3y)-28.56%
ROA(5y)N/A
ROE(3y)-75.91%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.52
Health
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 253.36%
Cap/Sales 17.02%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.54
Quick Ratio 0.53
Altman-Z N/A
F-Score3
WACC5.53%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-10553.8%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%27.17%
EPS Next Y92.72%
EPS Next 2Y41.42%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)35.31%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%5.72%
Revenue Next Year22.35%
Revenue Next 2Y24.4%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-566.72%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year95.67%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-2793.63%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1561.7%
OCF growth 3YN/A
OCF growth 5YN/A

TNL MEDIAGENE / TNMG FAQ

Can you provide the ChartMill fundamental rating for TNL MEDIAGENE?

ChartMill assigns a fundamental rating of 2 / 10 to TNMG.


Can you provide the valuation status for TNL MEDIAGENE?

ChartMill assigns a valuation rating of 1 / 10 to TNL MEDIAGENE (TNMG). This can be considered as Overvalued.


How profitable is TNL MEDIAGENE (TNMG) stock?

TNL MEDIAGENE (TNMG) has a profitability rating of 1 / 10.


What is the financial health of TNL MEDIAGENE (TNMG) stock?

The financial health rating of TNL MEDIAGENE (TNMG) is 1 / 10.